Major pharmaceutical companies, including Johnson & Johnson, GlaxoSmithKline, and Viatris, are key players in the Paracetamol Market.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Major pharmaceutical companies, including Johnson & Johnson, GlaxoSmithKline, and Viatris, are key players in the Paracetamol Market.
Who's involved
What this event is mainly aboutKeep exploring
Part of
The generic drug market is seeing significant growth, driven by Indian firms and regional markets, with major players like Aurobindo, J&J, and GSK involved.Also in this story
- BMY intended to expand manufacturing capacity in Europe and Japan, with Reuters reporting the decision.
- Sun Pharmaceutical Industries is identified as the largest drugmaker based in India.
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
GlaxoSmithKline
company in Tokyo, Japan
Nothing else this week.
-
Mylan
former pharmaceutical company
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswire[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate